FIELD: medicine, phytotherapy, pharmacy.
SUBSTANCE: invention relates to using Ginkgo biloba extracts comprising 20-30% of flavone glycosides, 2.5-4.5% of mainly gynkgolides A, B, C and J, 2-4% of bilobalide, less 10% of proanthocyanidines and less 10 ppm of compounds of alkylphenol type. Also, the invention relates to using the Ginkgo biloba extract of type Egb 761® for preparing a medicinal agent designated for prophylaxis and treatment of sarcopenia. Proposed extracts reduce age-dependent loss of muscle mass and increase the ratio of a muscle mass to the total body mass.
EFFECT: valuable medicinal properties of extracts.
5 cl, 1 tbl, 2 ex
